Literature DB >> 17962873

Prevalence and risk factors for chronic hepatitis B in HIV patients attended at a sexually-transmitted disease clinic in Vitória, Brazil.

Adriana Marchon Zago1, Thayla Ferrari Machado, Flavia Lagrota Cazarim, Angélica Espinosa Miranda.   

Abstract

This study assessed the prevalence of and correlated factors for chronic hepatitis B infection (HBV) among HIV patients attending the Reference Center for Sexually Transmitted Infections (STI) and AIDS in Vitória, ES, Brazil. HIV patients were studied from 1993 to 2004, using information recorded in a database of the STI Clinic. Demographic data, clinical characteristics, patterns of risk behavior and test results (ELISA-HIV, IFA-HIV, HBsAg, viral load and CD4 counts) were analyzed. We analyzed 851 HIV patients. Median age was 35.0 (interquartile range 30; 42) years and median years of education was 8.0 (IQR 5; 11). The prevalence of chronic HBV was 3.8% (95% CI 2.5-5.1). Illicit drug use was reported in 185 (21.7%) cases, alcohol abuse in 80 (9.4%) cases, men who have sex with men in 116 (13.6%) cases, and past STI in 320 (37.6%) cases. Chronic HBV was associated with intravenous drug use, male gender, STI associated with HIV diagnosis, and death. There is a need for prevention and assistance strategies to control the evolution of this infection in HIV patients.

Entities:  

Mesh:

Year:  2007        PMID: 17962873     DOI: 10.1590/s1413-86702007000500007

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  8 in total

1.  A population-based survey of the prevalence of HIV, syphilis, hepatitis B and hepatitis C infections, and associated risk factors among young women in Vitória, Brazil.

Authors:  Angelica Espinosa Miranda; Nínive Camilo Figueiredo; Renylena Schmidt; Kimberly Page-Shafer
Journal:  AIDS Behav       Date:  2008-04-10

2.  Hepatitis B: Epidemiology and prevention in developing countries.

Authors:  Elisabetta Franco; Barbara Bagnato; Maria Giulia Marino; Cristina Meleleo; Laura Serino; Laura Zaratti
Journal:  World J Hepatol       Date:  2012-03-27

3.  Disparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries.

Authors:  Joseph C Forbi; Yousr Ben-Ayed; Guo-liang Xia; Gilberto Vaughan; Jan Drobeniuc; William M Switzer; Yury E Khudyakov
Journal:  J Clin Virol       Date:  2013-07-17       Impact factor: 3.168

4.  Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil.

Authors:  Maria Cassia Mendes-Correa; João R R Pinho; Michele S Gomes-Gouvea; Adriana C da Silva; Cristina F Guastini; Luiz G Martins; Andréa G Leite; Mariliza H Silva; Reinaldo J Gianini; David E Uip
Journal:  BMC Infect Dis       Date:  2011-09-20       Impact factor: 3.090

5.  T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc.

Authors:  Patricia Araujo; Roger Y Dodd; Flavia Latinni; Renata Souza; Ricardo Diaz; Jose Augusto Barreto
Journal:  J Biomark       Date:  2013-12-03

6.  Prevalence of hepatitis B in people living with HIV/AIDS in Latin America and the Caribbean: a systematic review and meta-analysis.

Authors:  Fatima Mitiko Tengan; Edson Abdala; Marisa Nascimento; Wanderley Marques Bernardo; Antonio Alci Barone
Journal:  BMC Infect Dis       Date:  2017-08-24       Impact factor: 3.090

7.  Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia.

Authors:  Meseret Ayelign; Melak Aynalem; Nega Berhane
Journal:  Hepat Med       Date:  2021-11-11

8.  Prevalence of HBV in HIV Patients Referred to Imam Khomeini Hospital, Tehran, Iran from 2008-2010.

Authors:  Esmaeil Mohammad Nejad; Seyyedeh Roghayeh Ehsani; Narmela Rabirad; Roghayeh Deljo; Simin Ranjbarn; Shadi Rezaee; Zahra Tamizi
Journal:  Iran Red Crescent Med J       Date:  2013-04-05       Impact factor: 0.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.